Insmed, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4576693075
USD
205.04
-1.56 (-0.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Apellis Pharmaceuticals, Inc.
Exelixis, Inc.
Alkermes Plc
Intra-Cellular Therapies, Inc.
Perrigo Co. Plc
Jazz Pharmaceuticals Plc
Organon & Co.
Ionis Pharmaceuticals, Inc.
Catalent, Inc.
Insmed, Inc.
Karuna Therapeutics, Inc.
Why is Insmed, Inc. ?
1
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at USD -844.56 MM
  • ROCE(HY) Lowest at -160.54%
  • OPERATING PROFIT(Q) Lowest at USD -250.13 MM
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 182.12%, its profits have fallen by -22.6%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Insmed, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Insmed, Inc.
183.09%
5.11
48.71%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
19.41%
EBIT Growth (5y)
-217.66%
EBIT to Interest (avg)
-10.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.25
Tax Ratio
0.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
135.23
EV to EBIT
-15.70
EV to EBITDA
-15.91
EV to Capital Employed
75.96
EV to Sales
35.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-483.80%
ROE (Latest)
-896.32%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET PROFIT(HY)

Higher at USD -500.97 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.03 times

CASH AND EQV(HY)

Highest at USD 3,056.22 MM

NET SALES(Q)

Highest at USD 107.42 MM

-14What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -844.56 MM

ROCE(HY)

Lowest at -160.54%

OPERATING PROFIT(Q)

Lowest at USD -250.13 MM

PRE-TAX PROFIT(Q)

Lowest at USD -261.44 MM

NET PROFIT(Q)

Lowest at USD -262.69 MM

Here's what is working for Insmed, Inc.
Inventory Turnover Ratio
Highest at 1.03 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
Highest at USD 107.42 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 3,056.22 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation
Highest at USD 3.75 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Insmed, Inc.
Operating Cash Flow
Lowest at USD -844.56 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -250.13 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -261.44 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -262.69 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)